Novartis has signed an agreement to collaborate with Compact Imaging – to fund the development of a low-cost home-based monitor to detect disease progression in advanced cases of eye diseases, age-related macular degeneration (AMD) and diabetic retinopathy (DR).
If approved, goggles used at a patient's home could record a test result and upload it over the internet for a specialist to review, thereby potentially reducing clinical visits, saving doctors' and patients' time while delivering cost and efficiency savings to healthcare systems.
This collaboration demonstrates Novartis’s ongoing commitment to eye care and improving patient outcomes for age-related macular degeneration (AMD) and diabetic retinopathy (DR).
